Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ONTY $3.01 0.5000 +19.92%
CBMG $35.64 4.5100 +14.49%
BLRX $2.02 0.1700 +9.19%
XBIT $20.59 1.5400 +8.08%
INO $8.83 0.5700 +6.90%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CALA $11.00 -1.0200 -8.49%
TKAI $10.95 -0.9100 -7.67%
CLSN $2.63 -0.1701 -6.08%
CVM $0.75 -0.0400 -5.06%
BDSI $8.10 -0.3900 -4.59%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Barrett's Esophagus May Be Less Risky Than Thought

(WebMD) Oct 12, 2011 - People with Barrett's esophagus, a complication of heartburn and acid reflux disease, are at risk of developing a deadly kind of cancer at much lower rates than doctors previously believed, a new study shows.
read article 

Blacks Fare Worse Than Whites After Colon Cancer Surgery

(U.S. News & World Report/HealthDay News) Oct 12, 2011 - Black Americans who have surgery for stage 2 and stage 3 colon cancer have worse overall and recurrence-free survival rates than whites, a new study finds.
read article 

Many Cancer Survivors Struggle With Trauma Stress: Study

(Reuters) Oct 12, 2011 - A cancer diagnosis can leave lasting psychological scars akin to those inflicted by war, with the impact in some cases lasting for years, U.S. researchers found in a study.
read article 

What Parkinson’s Teaches Us About the Brain

(NYT/Well blog) Oct 12, 2011 - Scientific discoveries can be serendipitous, and so it was when Jay L. Alberts, then a Parkinson’s disease researcher at Emory University in Atlanta, mounted a tandem bike with Cathy Frazier, a Parkinson’s patient.
read article 

Cancer Drug Stent Keeps Leg Arteries Open: FDA Staff

(Chicago Tribune/Reuters) Oct 11, 2011 - Medical device reviewers said a Cook Medical stent coated with a common cancer-fighting drug was safe and effective for treating clogged arteries in the thighs.
read article 

When the Talk Turns to Taxes and Medicine

(New York Times) Oct 11, 2011 - The Republican debate covered a range of topics, including income and sales taxes, prostate cancer tests and tax holidays.
read article 

Kantar Health Adds Five New Tumor Types to CancerMPact(R) Treatment Architecture China

(Yahoo! Finance) Oct 12, 2011 - Kantar Health, a leading healthcare-focused global consultancy and marketing insights company with special expertise in oncology, announces the addition of five new tumor types to CancerMPact® Treatment Architecture China.
read article 

Health Options Worldwide and Cancer Treatment Centers of America Enter New Agreement

(CTCA) Oct 11, 2011 - Health Options Worldwide (HOW) and Cancer Treatment Centers of America (CTCA) have agreed to expand healthcare options and accessibility for cancer patients at all four CTCA regional destination hospitals in Chicago, Philadelphia, Phoenix and Tulsa.
read press release 

Regional Medical First Gives Fresh Hope to Family of Eight-Year-Old Girl with Recurrent Cancer

(Miami Children's Hospital) Oct 11, 2011 - A medical team at Miami Children’s Hospital performed the region’s first hyperthermic intraperitoneal chemotherapy (HIPEC) or “heated chemotherapy” surgical treatment on a pediatric patient on September 30, offering the child and family renewed hope after other treatment options were exhausted.
read press release 

Pink Ploy? Breast Cancer Charity Motives Doubted

(San Jose Mercury News/AP) Oct 11, 2011 - The country is awash in pink for breast cancer awareness month - and some women are sick of it.
read article 

Cancer Survival: Longer Lives, Unmet Needs

(ABC News) Oct 12, 2011 - When Nicole Malato, 34, was diagnosed with cancer of both breasts in May, she wondered not just about how quickly her surgeon could remove the tumors, but also what subsequent chemotherapy, radiation and hormone-blocking drugs would do to her heart, her bones and her brain decades from now.
read article 

Opinion: Why Block a Cancer Test that Saves Lives?

(Washington Post) Oct 11, 2011 - Forty years ago, my mother-in-law learned from a mammogram at age 57 that she had breast cancer. We immediately sought the best available treatment. She lived for many happy years and enjoyed precious time with her grandchildren.
read article (free registration required) 

Colo. Cancer Researchers to Share $9.55 Million Grant to Learn How Prostate Cancer Resists Treatment

(Colorado Cancer Center blog) Oct 11, 2011 - The National Cancer Institute (NCI) recently awarded a team of cancer biologists $9.55 million over five years to define the molecular changes that occur as prostate cancer progresses to the therapy-resistant state.
read article 

OctreoPharm Sciences Receives Orphan Drug Designation for SOMscan® for the Diagnosis of Neuroendocrine Tumours

(Yahoo! Finance) Oct 12, 2011 - OctreoPharm Sciences GmbH, a Berlin based specialist for radiopharmaceuticals, announced today that the European Medicines Agency has granted Orphan Drug status to OctreoPharm Sciences product SOMscan® for the diagnosis of gastro-entero-pancreatic neuroendocrine tumours.
read article 

Advaxis Granted pre-IND Meeting with FDA for ADXS-HER2, an Immunotherapy for HER2 Expressing Cancers

(Advaxis) Oct 11, 2011 - Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug (“IND”) meeting with the U.S. Food and Drug Administration (“FDA”) on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
read corporate press release 

Nation’s Top Patient Advocacy Groups Urge United States Senate Committee on Health, Education, Labor and Pensions to Support Investment in Health Prevention

(ACSCAN) Oct 12, 2011 - Today, leaders from the American Cancer Society Cancer Action Network, American Diabetes Association and American Heart Association will testify before the United States Senate Committee on Health, Education, Labor and Pensions on the need for a healthcare system that better incorporates, coordinates and values quality and prevention.
read press release 

Intellikine Initiates Phase I Study of Targeted Cancer Therapeutic INK1117

(MarketWatch) Oct 12, 2011 - Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that the first patient has been treated in a Phase I dose escalation study of INK1117 in patients with advanced solid malignancies.
read article 

Ginger Supplements Might Ease Inflammation Linked to Colon Cancer

(U.S. News & World Report/HealthDay News) Oct 11, 2011 - A small, preliminary study finds that ginger root supplements seem to reduce inflammation in the intestines -- a potential sign that the pills might reduce the risk of colon cancer.
read article 

Hispanic Women Have Higher Incidence of Rare Breast Tumor

(American College of Surgeons) Oct 11, 2011 - According to a study published in the October issue of the Journal of the American College of Surgeons, phyllodes tumors - rare breast malignancies accounting for 0.5 to one percent of all breast tumors - tend to be more prevalent in Hispanic patients.
read press release 

Women Who Exercise A lot Hit Menopause Earlier

(Reuters) Oct 11, 2011 - Women who spend a lot of time exercising or eat a heart-healthy diet appear to reach menopause earlier, according to a Japanese study -- findings that researchers say could be important for cancer prevention.
read article 

Colorado Test Helps Boost Survival Rates for Lung Cancer Patients

(Colorado Cancer Center blog) Oct 11, 2011 - Researchers at the University of Colorado Cancer Center have developed a test that identifies key biomarkers in advanced lung cancer that helped reduce the risk of death by 36 percent over a 30-month period in a recent clinical trial.
read article 

New Urine DNA Test Used with PSA Can Eliminate Unnecessary Biopsies and Reduce Fear of Overtreatment, Says Prostate Cancer Foundation

(Prostate Cancer Foundation) Oct 11, 2011 - One new biotechnology that may go a long way in detecting only prostate cancer and reducing unnecessary prostate cancer biopsies and possible subsequent overtreatment, is the development of a new urine test for prostate cancer.
read press release 

BSD Medical's Heat Delivery Device Shows Positive Results

(Reuters) Oct 12, 2011 - BSD Medical Corp said a study showed therapeutic heat combined with chemotherapy and radiation delivered through the company's heat delivery system increased survival in patients with pancreatic cancer.
read article 

Onyx Settles Claims with Bayer Over Cancer Drug

(CNBC/Reuters) Oct 12, 2011 - Germany's Bayer and its U.S. development partner Onyx have reached a settlement over a contested sister compound to their potential blockbuster cancer drug Nexavar.
read article 

Prostate Surgery Risks Greater for Elderly Men

(Reuters) Oct 11, 2011 - Elderly men who have prostate cancer surgery face heightened risks of complications -- and the majority have the procedure at hospitals with less-than-optimal outcomes, a U.S. study suggests.
read article